Safety and Efficacy of BAFF-R CART for Refractory Neuroimmune Diseases

NCT07022197 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

27

Enrollment

OTHER

Sponsor class

Conditions

Chronic Inflammatory Demyelinating Polyradiculoneuropathy
NMO Spectrum Disorder
Myasthenia Gravis
Idiopathic Inflammatory Myopathies

Interventions

DRUG: BAFF-R CART

Sponsor

Tianjin Medical University General Hospital